Acta clinica Croatica
-
Acta clinica Croatica · Dec 2023
Case ReportsTUBERCULOUS SPONDYLODISCITIS IN A RENAL TRANSPLANT RECIPIENT - A CASE REPORT.
Diagnosis of tuberculous spondylodiscitis is difficult because clinical findings usually are nonspecific and radiological features may mimic other bacterial, fungal, inflammatory and neoplastic diseases. We present the first reported case of tuberculous spondylodiscitis in a 56-year-old man successfully treated by rifampicin-containing anti tuberculosis regimen with close follow-up of serum cyclosporine levels.
-
The aim of this study was to assess whether COVID-19 affects thyroid function. The effect of COVID-19, which has involved the whole world in the last two years, on thyroid function is currently unknown. With the onset of the COVID-19 epidemic, 69,000 patients who presented to our hospital in the last 18 months and had the COVID-19 test were screened. ⋯ The levels recorded in COVID-19 positive patients (thyroid-stimulating hormone (TSH) 2.54±14.54 µIU/mL, free triiodothyronine (fT3) 0.84±1.49 pg/mL, free thyroxine (fT4) 0.99±0.42 ng/dL, antithyroid peroxidase antibody (anti TPO) 140.04±276.55 IU/mL, and antithyroglobulin antibody (anti TG) 16.31±22.99 IU/mL) were compared with those measured in COVID-19 negative patients (TSH 1.90±8.22 µIU/mL, fT3 0.78±1.60 pg/mL, fT4 0.99±0.42 ng/dL, anti TPO 122.55±263.39 IU/mL, and anti TG 56.25±185.64 IU/mL). There was no significant difference between COVID-19 positive patients and COVID-19 negative cases in terms of thyroid function (TSH, p=0.66; fT3, p=0.24; fT4, p=0.93; anti TPO, p=0.52; and anti TG, p=0.39). For now, it may be some consolation for us that the coronavirus disease, which affects almost all body systems, does not seem to affect thyroid function.